HighMark Wealth Management’s Apyx Medical APYX Stock Holding History

HighMark Wealth Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,000	Closed	-$18.4K	–	567
2026 Q1	$18.4K	Hold	5,000	–	–	0.01%	232
2025 Q4	$17.5K	Hold	5,000	–	–	0.01%	255
2025 Q3	$10.7K	Hold	5,000	–	–	﹤0.01%	293
2025 Q2	$11.3K	Hold	5,000	–	–	0.01%	294
2025 Q1	$6.85K	Hold	5,000	–	–	﹤0.01%	331
2024 Q4	$7.9K	Hold	5,000	–	–	﹤0.01%	327
2024 Q3	$6.2K	Hold	5,000	–	–	﹤0.01%	376
2024 Q2	$6.7K	Hold	5,000	–	–	﹤0.01%	345
2024 Q1	$6.8K	Hold	5,000	–	–	﹤0.01%	340
2023 Q4	$13.1K	Buy	+5,000	New	+$12.1K	0.01%	236

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HighMark Wealth Management's APYX Position: Q2 2026 in Review

HighMark Wealth Management sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 5,000 shares — an estimated $18.4K sold.

HighMark Wealth Management first reported a position in APYX in Q4 2023 and held it in 10 quarters. The position peaked at $18.4K in Q1 2026. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

HighMark Wealth Management reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
HighMark Wealth Management sold 5,000 Apyx Medical shares in Q2 2026, an estimated $18.4K.
HighMark Wealth Management first reported a position in Apyx Medical in Q4 2023 and held it in 10 quarters.
HighMark Wealth Management's Apyx Medical position peaked at $18.4K in Q1 2026.
68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.